News Center

位置：

Honors Announcement

Group News

Media Reports

Good News! Shijiazhuang Sihua Pharmaceutical Once Again Ranked Among China’s Top 100 Pharmaceutical Companies

Category:

Honors Announcement

发布时间：2022-12-18

【概要描述】 On December 18, the 2022 (39th) National Pharmaceutical Industry Information Conference, hosted by the China Pharmaceutical Industry Information Center of the Ministry of Industry and Information Technology, was held in Shanghai. During the conference, several highly anticipated industry rankings were unveiled, including the 2021 Top 100 Chinese Pharmaceutical Companies list. Shijiazhuang Sihua Pharmaceutical Co., Ltd. was honored on the 2021 Top 100 Chinese Pharmaceutical Companies list, ranking 59th—up 13 places from the previous year—and once again secured the prestigious title of “Best Industrial Enterprise for Pharmaceutical R&D Product Pipeline in China 2022” for the third consecutive year.

Good News! Shijiazhuang Sihua Pharmaceutical Once Again Ranked Among China’s Top 100 Pharmaceutical Companies

On December 18, the 2022 (39th) National Pharmaceutical Industry Information Conference, hosted by the China Pharmaceutical Industry Information Center of the Ministry of Industry and Information Technology, was held in Shanghai. During the conference, several highly anticipated industry rankings were unveiled, including the 2021 Top 100 Chinese Pharmaceutical Companies list. Shijiazhuang Sihua Pharmaceutical Co., Ltd. was honored on the 2021 Top 100 Chinese Pharmaceutical Companies list, ranking 59th—up 13 places from the previous year—and once again secured the prestigious title of “2022 Best Industrial Enterprise for Pharmaceutical R&D Product Lines” for the third consecutive year.

Over the past two years, Shijiazhuang No. 4 Pharmaceutical has fully leveraged its scale advantages, quality strengths, and brand reputation by aligning its innovation chain with the industrial value chain. The company has accelerated the R&D of specialty generic drugs, active pharmaceutical ingredients, innovative medicines, pharmaceutical packaging materials, and products undergoing bioequivalence evaluation, thereby establishing a tiered chemical-drug R&D system characterized by “developing a batch, translating a batch, and stockpiling a batch.” This approach has enabled synchronized development across the entire drug R&D–market translation value chain, resulting in a uniquely structured product portfolio and new competitive advantages in the industry. Continuous optimization of the product mix and ongoing refinement of the industrial chain have provided robust support for Shijiazhuang No. 4 Pharmaceutical’s rapid, high-quality growth and efficiency improvements, effectively propelling the company toward the mid- to high-end segments of the value chain. Over the past two years, the company’s core business volume and revenue have grown steadily, with operating results repeatedly reaching new highs, marking significant breakthroughs in its pursuit of high-quality development and placing it among the leaders in China’s pharmaceutical sector.

According to reports, the “Annual Top 100 Chinese Pharmaceutical Companies” ranking, organized by the China Pharmaceutical Industry Information Center under the Ministry of Industry and Information Technology of the People’s Republic of China, is the most authoritative and influential professional evaluation event in China’s pharmaceutical industry. The ranking is based on three key indicators—total assets, main business revenue, and total profit—and is compiled using legal entities of pharmaceutical manufacturing enterprises (including those with consolidated financial statements), thereby ensuring high levels of credibility and guidance. As such, it has garnered widespread attention from pharmaceutical companies, the industry at large, and the broader public.

Keywords:

Shijiazhuang Sihua Pharmaceutical Group’s Youyi Chemical has been recognized as a specialized, refined, distinctive, and innovative small and medium-sized enterprise in Hebei Province.

Shijiazhuang Sihua Pharmaceutical Group’s Bosheng Medical Devices Has Been Recognized as a “Specialized, Refined, Distinctive, and Innovative” Small and Medium-Sized Enterprise in Jiangsu Province.

Shijiazhuang Sihua Pharmaceutical Group’s Youyi Chemical has been recognized as a specialized, refined, distinctive, and innovative small and medium-sized enterprise in Hebei Province.